Fig. 3From: The value of 18F-PSMA-1007 PET/CT in identifying non-metastatic high-risk prostate cancer18F-PSMA-1007 PET/CT with CT (a), axial PET (b), fused PET/CT (c) and maximum-intensity projection (d) images of a 70-year-old patient (GS, 9; PSA, 37.910 ng/ml). This patient was classified into HR group. Axial PET (b) and fused PET/CT (c) images showed diffuse hypermetabolism in the prostate gland (SUVmax: 20.20)Back to article page